Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function

Urd Kielgast, Thure Krarup, Jens Juul Holst, Sten Madsbad, Thure Krarup

138 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab